Cross Country Healthcare Eyes Over $1B Revenue, 4%–5% EBITDA by 2026 with $400M Pipeline
Cross Country Healthcare secured over $400M in contract renewals and aims to surpass $1B in revenue with 4%–5% EBITDA margins by end-2026 through its Intellify platform and AI-driven efficiencies. It plans to expand Intellify into nursing, allied, locums and home-based staffing in 2026 and pursue accretive tuck-in acquisitions.
1. Revenue and Margin Targets
Cross Country Healthcare’s leadership reiterated confidence in exiting 2026 with more than $1 billion in revenue and 4%–5% EBITDA margins. The guidance rests on quarter-over-quarter growth, a strong balance sheet and market-leading technology.
2. Robust Contract Pipeline
The company has secured over $400 million in contract value through renewals, expansions and new wins, underpinning its revenue outlook and validating sales pipeline strength.
3. Intellify Expansion and AI Integration
Intellify, developed over four years, is set to roll out across nursing, allied, locums and home-based staffing in 2026. AI features are already enhancing credentialing, delivery speed and operating leverage to improve margins.
4. Capital Allocation and M&A Strategy
Leadership emphasized a disciplined, patient capital allocation approach, prioritizing investments in its technology platform and home-based staffing division while seeking accretive tuck-in acquisitions to drive consolidation and growth.